Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia

Purpose: To study the alterations in hormonal sensitivity in relation to proliferative activity during the development of cervical dysplasia in women infected with high-risk human papillomavirus (hr-HPV).

Methods: Three to five biopsies of the cervix of eight patients were taken at colposcopy. Dysplasia was detected in 22 of the 32 biopsies, and 20 of these 22 biopsies contained hr-HPV. The labeling index (LI) as well as the intensity of staining of the MIB-1-, estrogen receptor (ER)-, and progesterone receptor (PR)-expression was assessed in each biopsy, including normal epithelium directly adjacent to the dysplastic lesions.

Results: Statistical analysis showed a significant increase in the MIB-1 LI with increasing severity of the dysplasia. The ER LI and ER intensity of staining in dysplastic lesions, as well as in morphologically normal epithelium directly adjacent to the dysplasia, showed a significant inverse relation with the severity of the dysplasia. The PR LI and intensity of staining did not differ between normal epithelium and dysplasia. The ER/MIB-1 ratio (including the ER LI and ER intensity of staining), and the PR/MIB-1 ratio (intensity of staining only) in dysplastic lesions showed a significant inverse relation with the severity of the dysplasia, while no alterations in these ratios were observed in morphologically normal epithelium adjacent to the dysplasia.

Conclusion: Down regulation of ER expression may be the first alteration to take place in normal epithelium during the development of cervical dysplasia in women infected with hr-HPV. The significant decrease in the ER/MIB-1-, and PR/MIB-1-ratio in progressively dysplastic lesions indicates a loss of normal growth control by sex steroid hormones, which is not observed in normal epithelium.

Estrogen receptor; Progesterone receptor; Hyperproliferation; Cervical dysplasia

[1] Herrington C.S.: "Human papillomaviruses and cervical neoplasm. I. Classification, virology, pathology, and epidemiology". J. Clin. Pathol., 1994, 47, 1066.

[2] Chan S.Y., Delius H., Halpern A.L., Bernard H.U.: "Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy". J. Viral., 1995, 69, 3074.

[3] Meijer C.J.L.M., Rozendaal R., Verheijen R.M., Walboomers J.M.M.: "Clinical role of HPV testing". C.M.E. J. Gynecol. Oneal., 2000, 5, 26.

[4] Walboomers J.J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.

[5] Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A. et al.: "Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes". Cancer Res., 1999, 59, 6132.

[6] Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V.: "The causal relation between human papillomavirus and cervical cancer". J. Clin. Pathol., 2002, 55, 244.

[7] Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V. et al.: "Epidemiologic classification of human papillamavirus types associated with cervical cancer". N. Eng. J. Med., 2003, 348, 518.

[8] Konishi I., F ujii S., Nonogaki H., Nanbu Y., lwai T., Mori T.: "Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix". Cancer, 1991, 68, 1340.

[9] Bulten J., van der Laak J.A., Gemmink J.H., Pahlplatz M.M., de Wilde P.C., Hanselaar A.G.: "MIB-1, a promising marker for the classification of cervical intraepithelial neoplasia". J. Pathol., 1996, 178, 268.

[10] McCluggage W.G., Buhidma M., Tang L., Maxwell P., Bharucha H.: "Monoclonal antibody MIB-1 in the assessment of cervical squamous intraepithelial lesions". Int. J. Gynecol. Pathol., 1996, 15, 131.

[11] Al-Saleh W., Delvenne P., Greimers R., F ridman V., Doyen J., Boniver J.: "Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type". Am. J. Clin Pathol., 1995, 104, 154.

[12] Kim C.J., Um S.J., Kim T.Y., Kim E.J., Park T.C., Kim SJ. et al.: "Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells". Int. J. Gynecol. Cancer, 2000, 10, 157.

[13] Smith J.S., Green J., Berrington de Gonzalez A., Appleby P., Peto J., P lummer M., F ranceschi S., Beral V.: "Cervical cancer and use of hormonal contraceptives: a systematic review". Lancet, 2003, 361, 1159.

[14] Robertson D.I., P aslawski D., Duggan M.A., Stuart G.C., Nation J.G.: "Estrogen and progesterone receptor, human papillomavirus, and DNA ploidy analysis in invasive carcinoma of the cervix in pregnancy". Am. J. Clin. Pathol., 1993, 100, 18.

[15] Monsonego J., Magdelenat H., Catalan F., Coscas Y., Zerat L., Sastre X.: "Estrogen and progesterone receptors in cervical human papillomavirus related lesions". Int. J. Cancer, 1991, 48, 533.

[16] Nonogaki H., Fujii S., Konishi I., Nanbu Y., Ozaki S., Ishikawa Y., Mori T.: "Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix". Cancer, 1990, 66, 2620.

[17] Kanai M., Shiozawa T., Xin L., Nikaido T., F ujii S.: "lmrnunohistochemical detection of sex steroid receptors, cyclins, and cyclindependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix". Cancer, 1998, 82, 1709.

[18] Tervahauta A., Syrjanen S., Syrjanen K.: "Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix". Int. J. Gynecol. Pathol., 1994, 13, 234

[19] Coelho F.R.G., P rado J.C.M., P ereira Sobrinho J.S., Hamada G., Landman G. et al.: "Estrogen and progesterone receptors in human papilloma virus-related cervical neoplasia". Braz. J. Med. Biol. Res., 2004, 37, 83.

[20] Fonseca-Moutinho J.A., Cruz E., Carvalho L., Prazeres H.J.M., De Lacerda M.M.P., Da Silva D.P. et al.: "Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III". Int. J. Gynecol. Cancer, 2004, 14, 911.

[21] Melchers W.J., Bakkers J.M., Wang J., de Wilde P.C.M., Boonstra H., Quint W.G.V. et al.: "Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up". Am. J. Pathol., 1999, 155, 1473.

[22] Kleter B., van Doorn L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M. et al.: "Novel short-fragment P CR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses". Am. J. Pathol., 1998, 153, 1731.

[23] Kleter B., van Doorn L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J. et al.: "Development and clinical evaluation of a highly sensitive P CR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus". J. Clin. Microbial., 1999, 37, 2508.

[24] Quint W.G., Scholte G., van Doorn L.J., Kleter B., Smits P.H., Lindeman J.: "Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(lO) PCR and HPV genotyping". J. Pathol., 2001, 194, 51.

[25] Bekkers R.L.M., Melchers W.J.G., Bulten J., Hanselaar A.J.G.M., Quint W.G.V., Boonstra H., Massuger L.F.A.G.: "Localized distribution of human papillomavirus genotypes in the uterine cervix". Eur. J. Gynaecol. Oneal., 2002, 23, 203.

[26] Monsonego J., Valensi P., Zerat L., Clavel C., Birembaut P.: "Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia". Br. J. Obstet. Gynaecol., 1997, 104, 723.

[27] Speroff L., Glass R.H., Kase N.G. In: Clinical Gynecologic Endocrinology and Infertility, 5'h edition. Baltimore, Williams & Wilkins, 1994.

[28] Cunningham F.G., MacDonald P.C., Gant N.F. et al.: "Williams Obstetrics, 20th edition, Stanford CT, Appleton & Lange, 1997.

[29] Bulten J., de Wilde P.C., Boonstra H., Gemmink J.H., Hanselaar A.G.: "Proliferation in'atypical'atrophic pap smears". Gynecol. Oneal., 2000, 79, 225.

[30] Burghardt E., Ostor A.G.: "Site and origin of squamous cervical cancer: a histomorphological study". Obstet. Gynecol., 1983, 62, 117.

[31] Park J., Sun D., Genest D.R., Trivijitsilp P., Suh I., Crum C.P.: "Coexistence of low and high grade squamou& intraepithelial lesions of the cervix: Morphologic progression or multiple papillomaviruses?". Gynecol. Oneal., 1998, 70, 386.